Effective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab. [electronic resource]
Producer: 20050915Description: 771-4 p. digitalISSN:- 1042-8194
- Aged
- Alemtuzumab
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- therapeutic use
- Antigens, CD -- immunology
- Antigens, Neoplasm -- immunology
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- CD52 Antigen
- Glycoproteins -- immunology
- Humans
- Immunotherapy -- methods
- Lymphoma, T-Cell, Peripheral -- drug therapy
- Male
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.